Hyperlipoproteinemia Type 5
Symptoms, Doctors, Treatments, Advances & More

Hyperlipoproteinemia Type 5 Overview

Save information for later
Sign Up

Learn About Hyperlipoproteinemia Type 5

What is the definition of Hyperlipoproteinemia Type 5?
Hyperlipoproteinemia type V is a disorder of blood plasma fats (lipids) that can be inherited or acquired that is characterized by very low density lipoprotein, decreased low density lipoprotein (LDL), and high density lipoprotein (HDL). Hyperlipoproteinemia type V can increase the risk of developing cardiovascular diseases, such as stroke or heart attack.
What are the symptoms of Hyperlipoproteinemia Type 5?
Most individuals with hyperlipoproteinemia type V do not have any symptoms. The disease is usually discovered during an examination or upon symptoms of a stroke or heart attack. Some individuals with hyperlipoproteinemia type V may develop xanthomas (small, round, and whitish cholesterol deposits under the skin), especially around the eyes, and hypertriglyceridemic waist, which is an increased waist circumference > 90 cm in men or >85 cm in women.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyperlipoproteinemia Type 5?
Treatment for hyperlipoproteinemia type V includes medications administered alone or in combination such as statins (lovastatin, simvastatin, atorvastatin, or rosuvastatin), bile acid binding resins (cholestyramine or colestipol), fibric acid derivatives (gemfibrozil or bezafibrate), nicotinic acid derivatives (Niacin), and cholesterol absorption inhibitors (ezetimbe).
Who are the top Hyperlipoproteinemia Type 5 Local Doctors?
Experienced in Hyperlipoproteinemia Type 5
Dr. William N. Drake
Family Medicine
Experienced in Hyperlipoproteinemia Type 5
Dr. William N. Drake
Family Medicine
Before you request

Texas Health Family Care

10900 Founders Way, Suite 103, 
Fort Worth, TX 
817-741-8355
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Drake is a primary care provider, practicing in Family Medicine in Fort Worth, Texas. Dr. Drake is rated as an Experienced provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol. Dr. Drake is currently accepting new patients.

Experienced in Hyperlipoproteinemia Type 5
Dr. Arlin M. Myrmoe
Internal Medicine
Experienced in Hyperlipoproteinemia Type 5
Dr. Arlin M. Myrmoe
Internal Medicine
Before you request

Avera Medical Group Internal Medicine — Aberdeen

105 S State St, Suite 202, 
Aberdeen, SD 
605-622-5458
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arlin Myrmoe is a primary care provider, practicing in Internal Medicine in Aberdeen, South Dakota. Dr. Myrmoe is rated as an Experienced provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Renovascular Hypertension, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Hypertension. Dr. Myrmoe is board certified in American Board Of Internal Medicine. Dr. Myrmoe is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Hyperlipoproteinemia Type 5
Advanced in Hyperlipoproteinemia Type 5
Referral may be required

OSF Cardiovascular Institute

1000 West Harlem Avenue, 
Monmouth, IL 
309-343-7775
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Christopher Powers is a Cardiologist practicing medicine in Monmouth, Illinois. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Fainting, Stable Angina, Angina, and Pacemaker Implantation. Dr. Powers is board certified in American Board Of Internal Medicine. Dr. Powers is currently accepting new patients.

View All Doctors
What are the latest Hyperlipoproteinemia Type 5 Clinical Trials?
A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
Enrollment Status: Recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Phase: Phase 1

Summary: This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available treatments.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials